Simon John Rattle

Title: Simon John Rattle: Innovator in Ovarian Reserve Testing

Introduction

Simon John Rattle is a notable inventor based in Kingston-upon-Thames, GB. He has made significant contributions to the field of medical diagnostics, particularly in the area of ovarian reserve assessment. His innovative approach has the potential to change how ovarian reserve is evaluated, making it more accessible and efficient.

Latest Patents

Rattle holds a patent for a urine assay for ovarian reserve. This invention provides a urine test that is equivalent in sensitivity to current laboratory methods that determine ovarian reserve based on FSH levels in serum. The lateral flow device disclosed in the patent includes an application zone for receiving a urine sample, a labeling zone containing a label that binds to FSH in the sample, and a detection zone where FSH-bound label is retained. The detection zone has a threshold value corresponding to a serum FSH level of between 5-20 mIU/ml, with a specific example being 10 mIU/ml. A test result above this threshold indicates diminished ovarian reserve.

Career Highlights

Throughout his career, Simon John Rattle has worked with various companies, including Genosis (UK) Limited and Church Dwight & Co., Inc. His experience in these organizations has contributed to his expertise in medical diagnostics and innovation.

Collaborations

Rattle has collaborated with notable professionals in his field, including Paul North Bateman. These partnerships have likely enhanced his research and development efforts, leading to impactful inventions.

Conclusion

Simon John Rattle is a pioneering inventor whose work in ovarian reserve testing exemplifies innovation in medical diagnostics. His contributions are poised to make a significant impact on women's health.